INGREDIENTS
Active Ingredient: Body Protective Compound
Other Ingredients: Rice Powder, Microcrystalline Cellulose, Vegetable Capsule (Hypromellose)
BENEFITS
- joint and soft tissue support
- promotes digestive function
- neurological support
- endothelial nitric oxide production
FOR THOSE NEEDING
- Digestive Support; Both Upper & Lower
- Musculoskeletal Support
- Gut Brain Axis Protocols
- Immune System Support
OVERVIEW
BPC-157 is predominately indicated for joint and/or digestive (upper/lower) support.
DOSAGE FOR DOGS (and CATS)
The current recommendation is to go by the dosage protocol for an average sized human, to calculate the amount per pound body weight, and then apply the same mcg/lb dosage to your dog/cat.
Typical suggested dose for a 150 lb person is 250-500 mcg of BPC-157 orally each day (1.67- 3.33 mcg per lb body weight), so a 60 lb dog would take 100-200 mcg/day of BPC-157.
Multiply your pet’s body weight x 1.67 (low dose) or 3.33 (higher dose) to get their daily dose. Ideally, give this amount in divided doses, 2x/day.
Current research in dogs and rats showed that BPC-157 is nontoxic at even high doses.
FOR CATS (updated Sept 2024) Unfortunately, there's a lack of research available regarding the use of BPC-157 in cats/felines. However, we have spoken with at least one veterinarian who has been using BPC-157 with her feline clients with very good results. Because we have witnessed some incredible recoveries and astounding cures in our canine clients that have used BPC-157, we would suggest using BPC-157 in cats *with veterinary oversight and careful monitoring*. This could be absolutely life-changing (indeed, lifesaving!) for certain animals - especially cats with IBD. If you have "tried everything" and yet, your animal continues to suffer or is in decline, BPC-157 may be something for you to consider.
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds: https://pubmed.ncbi.nlm.nih.gov/32334036/
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794587/
BPC 157's effect on healing: BPC 157's effect on healing - ScienceDirect
Peptides In Veterinary Medicine: Peptides In Veterinary Peptides Medicine (bachem.com)
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
Panel Chuanyang Xu a 1, Lijuan Sun b 1, FengLing Ren c, Ping Huang d, Zhuang Tian d, Jiazhen Cui d, Wangqian Zhang a, Shuning Wang a, Kuo Zhang a, Lei He a, Wei Zhang a, Cun Zhang a, Qiang Hao a, Yingqi Zhang a, Meng Li a, Weina Li a
Show more https://doi.org/10.1016/j.yrtph.2020.104665
Highlights
-
- BPC157 did not show any test-related effects in the single-dose toxicity study.
- BPC157 was well tolerated in repeated-dose toxicity evaluations.
- BPC157 caused mild local irritation and showed good tolerance.
- BPC157 showed no genetic or embryo-fetal toxicity.
Abstract
BPC157 displays protective activity in various organs and tissues. This report presents preclinical toxicity studies with BPC157 in mice, rats, rabbits and dogs. The single-dose toxicity study did not show any test-related effects that could be attributed to the test article. In repeated-dose toxicity evaluations, BPC157 was well tolerated in dogs, with no abnormal changes between the BPC157-treated groups and the solvent control group, with the exception of a decrease in creatinine level at a dose of 2 mg/kg but not at lower doses. The animals recovered spontaneously after 2 weeks of withdrawal. This may be due to the pharmacological activity of BPC157. A local tolerance test showed that the irritation caused by BPC157 was mild. BPC157 also showed no genetic or embryo-fetal toxicity. In summary, BPC157 was well tolerated and did not cause any serious toxicity in mice, rats, rabbits and dogs. These preclinical safety data contribute to the initiation of an ongoing clinical study. Based on the stability and protective effect of BPC157, which has been widely reported, BPC157 may have a better application prospect than the widely used cytokine drugs in wound therapy.
BPC-157 Peptide Benefits, Side Effects, Dosage and Safety by Jay Campbell, November 27, 2019
BPC-157’s primary benefit is by and large its ability to accelerate the healing of many different wounds.
Tendons: BPC-157 was discovered to dramatically speed up the healing of tendons through the outgrowth of tendon explants and the spreading of tendon fibroblasts.
BPC-157 is also capable of healing detached or disjoined Achilles tendon.
Muscles: If you’re suffering from discomfort due to muscle sprains, tears and damage, you may find BPC-157 to be VERY useful.
In particular, one study found BPC-157 to be effective in healing quadriceps muscles that have been torn and crushed.
Muscle tears have also been observed to recover much faster with BPC-157 administration, even when the healing process is impaired by the systemic use of corticosteroids.
Bones: One promising study done in rabbits found that BPC-157 led to significant improvements in the healing of bone wounds and fractures.
Another study conducted in rats found BPC-157 to be instrumental in the healing of spinal cord injuries, and consequently a restoration of function in rats.
Ligaments: BPC-157 can lead to superior healing of damaged ligaments, along with tendon-to-bone healing.
A rat study conducted in 2010 found that BPC-157 lead to the healing of acute ligament injuries within rats.
In their own words, rats injected with BPC-157 “exhibited consistent functional, biomechanical, macroscopic and histological healing improvements”.
Skin Burns: BPC-157 can heal skin burns at a much faster rate by increasing blood flow to damaged tissues.
BPC-157 Peptide Benefits, Side Effects, Dosage and Safety By Jay Campbell, November 27, 2019